When it comes to issues of vitamin D in chronic kidney disease (CKD), core certainties include that most patients with CKD have dysregulated 25-hydroxy vitamin D […]

Patients undergoing kidney transplantation in regions with the highest heat indexes show increased rates of kidney function decline and major adverse kidney events (MAKEs) compared with […]

BOSTON — Sparsentan, a first-in-class, oral dual endothelin-angiotensin receptor antagonist, shows significant benefit in reducing proteinuria in the difficult-to-manage focal segmental glomerulosclerosis (FSGS) compared with the […]

BOSTON — The prominent headline from the highly anticipated Diuretic Comparison Project (DCP), published in late 2022, was that the antihypertensive drugs chlorthalidone and hydrochlorothiazide showed […]

A new drug has received a quick federal nod for adults with a serious kidney disorder known as primary immunoglobulin A nephropathy (IgAN). The drug is […]

Nearly a year after performing the first transplant of a pig kidney into a living human recipient, Massachusetts General Hospital (MGH), Boston, reported that a second […]

With efforts underway to expand access to the kidney transplant waiting list to more patients, including many with end-stage kidney disease (ESKD), new research underscored the […]

March 21, 2025 — The FDA has approved a drug as the first and only treatment for adults with C3 glomerulopathy (C3G) to reduce protein in […]